← Open Payments lookup

MAY KATHARINE LEHMAN: Open Payments

NPI 1073939385 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$354 in 9 payments from 8 companies in 2025. Trend: 2023 $464 · 2024 $290 · 2025 $354

Food & beverage: $354
CompanyPaymentsAmount
Edwards Lifesciences Corporation1$126
Amgen Inc.2$54
Alnylam Pharmaceuticals Inc.1$38
Smith+Nephew, Inc.1$35
W. L. Gore & Associates, Inc.1$29
Novartis Pharmaceuticals Corporation1$27
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)1$26
AstraZeneca Pharmaceuticals LP1$21

Products named: REPATHA, AMVUTTRA, COLLAGENASE SANTYL, GORE VIABAHN VBX Balloon Expandable Endo, LEQVIO, LifeVest, FARXIGA.

Industry payments across WY — which companies pay providers there.